Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTSV
1701
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $2.12M | ﹤0.01% |
53,800
+8,400
| +19% | +$135K |
|
1702
Trupanion
TRUP
$1.36B
| $2.12M | ﹤0.01% |
56,510
+2,200
| +4% | +$64.6K |
|
|
ARCH
1703
DELISTED
Arch Resources, Inc.
ARCH
| $2.12M | ﹤0.01% |
29,500
-600
| -2% | -$46K |
|
|
EVRI
1704
DELISTED
Everi Holdings
EVRI
| $2.11M | ﹤0.01% |
157,400
+23,900
| +18% | +$273K |
|
1705
TFS Financial
TFSL
$4.93B
| $2.11M | ﹤0.01% |
107,200
+2,000
| +2% | +$38.6K |
|
1706
Acushnet Holdings
GOLF
$5.25B
| $2.11M | ﹤0.01% |
64,900
+1,200
| +2% | +$35.7K |
|
|
BRSP
1707
BrightSpire Capital
BRSP
$629M
| $2.11M | ﹤0.01% |
160,000
+3,000
| +2% | +$40.8K |
|
|
DMC
1708
Del Monte Corp
DMC
$1.44B
| $2.11M | ﹤0.01% |
60,200
+1,100
| +2% | +$35.2K |
|
1709
Theravance Biopharma
TBPH
$878M
| $2.11M | ﹤0.01% |
81,342
+2,300
| +3% | +$44.7K |
|
|
ATRI
1710
DELISTED
Atrion Corp
ATRI
| $2.11M | ﹤0.01% |
2,802
| – | – |
|
1711
Radware
RDWR
$1.25B
| $2.09M | ﹤0.01% |
80,900
+1,400
| +2% | +$33.1K |
|
|
EVOP
1712
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $2.08M | ﹤0.01% |
78,900
+10,900
| +16% | +$300K |
|
1713
Denali Therapeutics
DNLI
$3.97B
| $2.08M | ﹤0.01% |
119,300
+3,000
| +3% | +$49.9K |
|
1714
Groupon
GRPN
$894M
| $2.08M | ﹤0.01% |
43,463
+1,020
| +2% | +$56.6K |
|
1715
M/I Homes
MHO
$3.9B
| $2.08M | ﹤0.01% |
52,800
+1,200
| +2% | +$50.2K |
|
1716
Piper Sandler
PIPR
$5.54B
| $2.06M | ﹤0.01% |
103,200
+1,200
| +1% | +$23.2K |
|
|
HEES
1717
DELISTED
H&E Equipment Services
HEES
| $2.06M | ﹤0.01% |
61,600
+1,100
| +2% | +$35.7K |
|
1718
Standard Motor Products
SMP
$870M
| $2.05M | ﹤0.01% |
38,500
+900
| +2% | +$45.9K |
|
|
QEP
1719
DELISTED
QEP RESOURCES, INC.
QEP
| $2.05M | ﹤0.01% |
455,442
+8,800
| +2% | +$30.7K |
|
1720
Clear Channel Outdoor Holdings
CCO
$1.18B
| $2.04M | ﹤0.01% |
713,500
+14,000
| +2% | +$35.4K |
|
|
TIVO
1721
DELISTED
Tivo Inc
TIVO
| $2.04M | ﹤0.01% |
240,713
+6,200
| +3% | +$49K |
|
|
NEX
1722
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $2.04M | ﹤0.01% |
303,833
+216,633
| +248% | +$1.17M |
|
1723
Photronics
PLAB
$1.97B
| $2.02M | ﹤0.01% |
128,500
+2,800
| +2% | +$35.2K |
|
|
ARR
1724
Armour Residential REIT
ARR
$2.37B
| $2.02M | ﹤0.01% |
22,642
+220
| +1% | +$18.8K |
|
1725
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $2.02M | ﹤0.01% |
68,429
+1,300
| +2% | +$37K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.